Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia

    ... of platelets and it now appears also hematopoietic stem cells . Eltrombopag can be given orally and has been approved by the FDA for ...

    Interview last updated 07/06/2012 - 3:42pm.

  2. Eltrombopag Added to IST Yields Encouraging Results

    ... current work demonstrates that stimulating remaining stem cells with a drug that mimics the actions of a natural growth substance for ...

    Interview last updated 05/24/2017 - 7:44am.

  3. Disease progression in myelodysplastic syndromes: do mesenchymal cells pave the way?

    Journal Title:  Cell Stem Cell Primary Author:  ... permissive niche has been implicated. In this issue of Cell Stem Cell, Medyouf et al. (2014) provide insights into the role of the niche ...

    Research Article last updated 06/19/2014 - 1:01pm.

  4. Aplastic Anemia

    ... Blood consists of blood cells floating in plasma . Plasma is mostly made of water. It also includes ... inside certain bones. Marrow contains blood-forming stem cells that make copies of themselves to create all three types of blood ...

    Page last updated 02/27/2017 - 7:34am.

  5. Personalized medicine for MDS

    ... can also help to detect abnormal clonal populations of cells.  -The results of the bone marrow provide important information that ... for a more intensive treatment, such as allogeneic stem cell transplant , earlier in the course of disease.  This personalized ...

    Research Review last updated 05/02/2016 - 9:44am.

  6. AAMDSIF Summer Fellowship Grant Program

    ... by profound decrease of the number of red blood cells, white blood cells, and platelets in the blood stream, leading to ... can improve inflammation in bone marrow (BM) allowing stem cells to survive. In this study, we seek to investigate the genetic ...

    Page last updated 05/17/2017 - 1:29pm.

  7. Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells

    ... and isogenic karyotypically normal induced pluripotent stem cells (iPSCs) from hematopoietic cells of MDS patients and show that the ...

    Research Article last updated 04/08/2015 - 9:33am.

  8. CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q).

    ... β-catenin activation and expansion of haematopoietic stem cells (HSC). We have screened a large cohort of 104 del(5q) MDS patients ...

    Research Article last updated 07/08/2015 - 11:46am.

  9. Shirley O’Brien’s Remarkable Response in a Clinical Trial

    ... syndrome (MDS), a disease that has no cure except for a stem cell transplant . Because I was in my mid-70s, a bone marrow ... causes my disease. The two pills each day allows the white cells to mature properly into normal cells. The bone marrow is no longer ...

    Patient Chronicle last updated 07/19/2017 - 8:12am.

  10. Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide

    ... Myelodysplastic syndrome (MDS) is a hematopoietic stem cell disorder primarily affecting CD34+ cells, characterized by ineffective hematopoiesis , often transforming ...

    Research Article last updated 04/17/2014 - 11:29am.